Skip to contents
In This Issue:
Souheil El-Chemaly, MD, MPH, of BWH’s Pulmonary Division, was named clinical director of BWH’s Center for LAM Research and Clinical Care last month.
The LAM center is focused on providing excellence in clinical care and offering access to the most up-to-date clinical trials for patients with lymphangioleiomyomatosis (LAM), a rare lung disease affecting only women, primarily of child-bearing age.
“Since LAM is a multisystem disease affecting the lungs, kidneys and brain, we work to provide the best possible care in a multidisciplinary fashion,” said El-Chemaly. “It is a privilege to be able to work with these courageous patients in a clinical setting and learn more about the disease through research.”
Before joining BWH two years ago, El-Chemaly completed post-doctorate fellowships in pulmonary and critical care at the National Institutes of Health (NIH) and the University of Miami. He received his MD from Saint Joseph’s University and his MPH from American University, both in Beirut, Lebanon. El-Chemaly completed his residency in internal medicine at St. Luke’s-Roosevelt Hospital Center, a teaching affiliate of Columbia University College of Physicians & Surgeons.
El-Chemaly’s research interest is lymphatics in lung disease. During his time at the NIH, he worked with one of the largest registries of LAM patients in the world.